Belupo

Belupo Pharmaceuticals and Cosmetics Inc. is one of leading Croatian pharmaceutical company, which apart from Croatia, operates in 18 European countries. Belupo is committed to maintaining of its strong position in Rx and OTC segments and to development and launch new products with stronger expansion in OTC segment, both regionally and globally. Belupos's vision is to become one of leading pharmaceutical companies in Central and Eastern Europe. Belupo have been manufacturing drugs since 1971 and was expanding its manufacturing capabilities through several significant greenfield investments, with last one finished in 2017, the new solid and semi-solid plants. Mid-term Belupo's strategic goal is further expansion into CEE and SEE markets, especially the CIS countries, with more focus on several new therapeutic groups and further diversification of the current portfolio.